Form 4: Guardant Health Executive Sells Shares
Insider Transaction (Form 4)
Chris Freeman, Chief Commercial Officer of Guardant Health, Inc., sold 63,605 shares of common stock on August 10, 2026.
Summary
- Option exercise/conversion: acquired 35,412 Common Stock at $110.49 ($3,912,672) on August 10, 2026; holds 100,786 after (Direct).
- Option exercise/conversion: acquired 28,193 Common Stock at $28.37 ($799,835) on August 10, 2026; holds 128,979 after (Direct).
- Open-market sale: disposed of 3,463 Common Stock at $167.38 ($579,639) on August 10, 2026; holds 125,516 after (Direct).
- Open-market sale: disposed of 7,365 Common Stock at $168.79 ($1,243,145) on August 10, 2026; holds 118,151 after (Direct).
- Open-market sale: disposed of 35,364 Common Stock at $169.63 ($5,998,926) on August 10, 2026; holds 82,787 after (Direct).
- Open-market sale: disposed of 17,413 Common Stock at $170.24 ($2,964,401) on August 10, 2026; holds 65,374 after (Direct).
- Option exercise/conversion: disposed of 35,412 Stock Option (Right to Buy) on August 10, 2026; holds 3,620 after (Direct).
- Option exercise/conversion: disposed of 28,193 Stock Option (Right to Buy) on August 10, 2026; holds 1,668 after (Direct).
Sentiment
Score: 2
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $10,786,111 of stock on the open market.
Insider Transactions
Chris Freeman — Officer (Chief Commercial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-10 | Option exercise/conversion | Common Stock | 35,412 | $110 | $3.9M | 100,786 |
| 2026-08-10 | Option exercise/conversion | Common Stock | 28,193 | $28 | $799.8K | 128,979 |
| 2026-08-10 | Open-market sale | Common Stock | 3,463 | $167 | $579.6K | 125,516 |
| 2026-08-10 | Open-market sale | Common Stock | 7,365 | $169 | $1.2M | 118,151 |
| 2026-08-10 | Open-market sale | Common Stock | 35,364 | $170 | $6.0M | 82,787 |
| 2026-08-10 | Open-market sale | Common Stock | 17,413 | $170 | $3.0M | 65,374 |
| 2026-08-10 | Option exercise/conversion | Stock Option (Right to Buy) | 35,412 | — | — | 3,620 |
| 2026-08-10 | Option exercise/conversion | Stock Option (Right to Buy) | 28,193 | — | — | 1,668 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-10 | Option exercise/conversion (35,412 shares) |
| 2026-08-10 | Option exercise/conversion (28,193 shares) |
| 2026-08-10 | Open-market sale (3,463 shares) |
| 2026-08-10 | Open-market sale (7,365 shares) |
| 2026-08-10 | Open-market sale (35,364 shares) |
| 2026-08-10 | Open-market sale (17,413 shares) |
| 2026-08-10 | Option exercise/conversion (35,412 shares) |
| 2026-08-10 | Option exercise/conversion (28,193 shares) |
Keywords
insider transaction, Form 4, GH, Guardant Health, Inc., bearish, Chris Freeman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.